Pharmaceutical composition for use as a retinal pigment epitheli

Details Pharmaceutical composition for use as a retinal pigment epitheli Pharmaceutical composition for use as a retinal pigment epitheli

1995-03-15

1998-02-24

Fay, Zohreh

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514885, 514912, A61K 3700

Patent

active

057212066

ABSTRACT:
A pharmaceutical composition for use as a retinal pigment epithelial cell growth stimulating agent comprising an interferon and a pharmaceutically acceptable carrier is disclosed. The composition is useful as a therapeutic agent for oculopathies, such as pigmentary retinal degeneration, central chorioretinopathy, and macular dystrophy.

REFERENCES:
Medline Abstract of Ophthalmic Research (1994) 26 (1) 1-7.
Medline Abstract of ACTA Neurologica Belgica (1994). Lyon-Caen et al.
WPID 147503, 1988.
Tobe et al., Journal of Japanese Opthalmological Society, vol. 98, Supplement, Abstract T1-51 (Mar. 15, 1995).
Tobe et al., J. Japanese Ophthalmological Society 99(5) :558-570 (1995).
Tobe et al., J. Japanese Ophthalmological Society 99(7) :792-805 (1995).
Tobe et al., J. Japanese Ophthalmological Society 99(5) :571-581 (1995).
Tobe et al., "Influence on Reconstruction Process of Choriocapillaris After Photocoagulation of Retina by Interferon-.beta." (Sep. 17, 1993).

Affiliated with

Also associated with

Rating

Pharmaceutical composition for use as a retinal pigment epitheli does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for use as a retinal pigment epitheli, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for use as a retinal pigment epitheli will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1875193